Sign in
Not yet recruitingNo phase

tDCS and Symptom Provocation in Treatment-Resistant OCD

Key facts

Who runs it
Centre Hospitalier Henri Laborit
Where
France6 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
178 people, planned
Starts
1 Dec 2026
Expected to end
15 Oct 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • tDCS session
  • symptom provocation
Record updated
21 October 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Diagnosis of Obsessive-Compulsive Disorder (OCD) according to DSM-5, with a duration ≥ 2 years
  • Good insight, defined as a BABS score ≤ 18
  • Chronic OCD, with either a Y-BOCS total score > 20 or a subscale score > 15
  • Treatment-resistant OCD, defined as:; failure of ≥ two adequate trials of SSRIs, or; failure of one SSRI plus augmentation with an atypical antipsychotic,
  • and/or insufficient response after ≥ one year of cognitive-behavioural therapy
  • Stable pharmacological treatment (fixed antidepressant dose) for at least 12 weeks prior to inclusion, with no significant improvement during this period
  • Age 18 to 70 years
  • Ability to provide informed written consent
  • Affiliation with the French social security system

Who cannot take part

  • Compulsory psychiatric hospitalisation
  • Current DSM-5 Axis I disorder other than OCD (schizophrenia spectrum, bipolar disorder, substance use)
  • History of traumatic brain injury
  • Presence of intracranial metal, pacemaker, or epilepsy
  • Women of childbearing potential without effective contraception, or those unwilling to maintain abstinence or contraception
  • Pregnancy or breastfeeding
  • Legal guardianship or curatorship
  • Current major depressive episode (MADRS > 21)
  • Suicide risk (MADRS item 10 > 3)
  • Dermatological lesions at electrode placement sites
  • Emergency situations or inability to provide informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if symptom provocation before transcranial Direct Current Stimulation (tDCS) in Obsessive-Compulsive Disorder (OCD) patients. The main question it aims to answer is:

Read full original descriptionShow less

Can symptom-provocation before tDCS improve therapeutic response in OCD patients ?

Researchers will compare the clinical outcomes of OCD patients having received, in one arm, tDCS and, in the other arm, patients having received tDCS preceded by symptom provocation to see if therapeutic response and various other clinical variables differ.

The 2 groups in the trial

  • tDCSSham treatment, for comparison

    These patients will only receive tDCS

    Treatment: tDCS session

  • tDCS + symptom provocationExisting treatment, for comparison

    These patients will experience symptom provocation followed with tDCS

    Treatment: tDCS session and symptom provocation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Transcranial Direct Current Stimulation Associated With Symptom Provocation in the Management of Patients With Treatment-Resistant Obsessive-Compulsive Disorder.
Fit questions
Built from NCT07429500, who can take part
Record updated
21 October 2026